Transaction
European Bank for Reconstruction and Development's (EBRD) Investment in Ibnsina Pharma's Operations in Egypt for EGP 1.3bn
- Announced
- 29 January 2026
- Target
- Ibn Sina Pharma Company S.A.E.
- Value
- $27.7m
- Asset class
- Private Credit
- Type
- Debt Financing
- Instrument
- Term Loan
- Lead investors
- European Bank for Reconstruction and Development (EBRD)
- Investors
- European Bank for Reconstruction and Development (EBRD)
- Sector
- Healthcare / Pharmaceuticals
- Markets
- Egypt
About the target
Ibnsina Pharma S.A.E. is an Egypt-based supply chain management company specialising in the distribution of pharmaceutical and cosmetic products. Established in 2001 and headquartered in New Cairo, Egypt, the company serves as a link between manufacturers and point-of-sale entities, including pharmacies, hospitals, and wholesalers. It operates a nationwide network of distribution centres and warehouses, utilising a fleet of transport vehicles to ensure coverage across the Egyptian governorates. The company is listed on the Egyptian Exchange (EGX) under the ticker ISPH. As of recent reporting, Ibnsina Pharma commands a significant share of the Egyptian market, distributing products for over 350 suppliers to more than 46,000 clients.
Sources
- solarquarter.com
- Partner Researchers